Speaker Spotlight – 2016 National Conference Edition Part 7

drmetz

David C. Metz, MD

Professor of Medicine
Division of Gastroenterology
Hospital of University of Pennsylvania
Philadelphia, PA

pennmedicine

Bio:

Dr Metz is Professor of Medicine and Associate Chief for Clinical Affairs in the Division of Gastroenterology at the University of Pennsylvania in Philadelphia, where he is director of the Acid-Peptic Disease Program and codirector of the GI Physiology Laboratory, the Swallowing Disorders Program and the Neuroendocrine Tumor Program.

He is actively involved in clinical research, patient care, and teaching of students, residents, and fellows. Dr Metz’s clinical research program is particularly active in acid-peptic conditions including hypersecretory states such as Zollinger-Ellison syndrome, Helicobacter pylori infection, nonsteroidal anti-inflammatory drug gastropathy, and gastroesophageal reflux disease. He also has particular expertise in the diagnosis and management of patients with functional and non-functional neuroendocrine tumors of the pancreas and alimentary tract. He has been a principal investigator on a number of trials evaluating upper gastrointestinal disease states. He is also active in national gastroenterology societies and was a prior member of the Liason Committee for Recertification of the American Board of Internal Medicine (American Gastroenterological Association representative) and the US Food and Drug Administration Gastrointestinal Drugs Advisory Committee. He is vice chair of the North American Neuroendocrine Tumor Society (NANETS)

Dr Metz earned his MBBCh (MD equivalent) from the University of the Witwatersrand in Johannesburg, South Africa. He moved to the United States in 1986 and pursued a residency in internal medicine at Albert Einstein Medical Center in Philadelphia. He completed a fellowship in gastroenterology in Washington, DC, in the combined Georgetown/Veterans Affairs Medical Center/National Institutes of Health (NIH) program. He remained on staff at the NIH for 2 more years as a senior staff fellow, performing basic research in pancreatic acinar cell secretion and clinical research in Zollinger-Ellison syndrome specifically.

In 1993, Dr Metz moved to Philadelphia in the role of Assistant Professor in the clinician educator track at the University of Pennsylvania. He was promoted to Associate Professor in 1998 and Full Professor in 2003.

To make an appointment, please contact:

Bonnie Bennett at (215) 349-5562

Perelman Center for Advanced Medicine                                                                        South Pavilion, 4th Floor                                                                                                        3400 Civic Center Boulevard                                                                                 Philadelphia, PA 19104                                                                                                            (800) 789-PENN (7366)

For more information on Dr. David Metz and Penn Medicine at the University of Pennsylvania, please visit their website here.

Dr. Metz at the 2016 National NET Patient Conference:

Topic: The Role of the Gastroenterologist in Diagnosing and Treating NETs

When: Friday, September 23th, 2016 at 10:15AM*

SIGN UP NOW FOR THE 2016 NATIONAL NET PATIENT CONFERENCE in New Orleans, LA from September 22-24th to see Dr. Metz and 19 other experts speak on Neuroendocrine Cancer! 

Registration is $125 per person including

  • Thursday’s Welcome Reception 
  • Breakfast, Lunch, and snacks for both Friday and Saturday
  • And keep your eyes out for some special prizes!

Registration does not include your hotel stay or travel expenses.

For more information and to buy your ticket, click here!!

*Time and Date are subject to change.

To check out some of our other speakers, click here!

The Speaker Spotlight – 2016 National Conference Edition

Welcome to the NETCancerAwarenessBlog’s first of the Speaker Spotlight Series-2016 National Conference Edition!!

drwolin

Edward M. Wolin, MD

Director, Neuroendocrine Tumor Program, Montefiore Einstein Center for Cancer Care

Montefiore

Department: Oncology

Bio:

Edward M. Wolin, MD is an internationally recognized Neuroendocrine Medical Oncologist. Patients from all over the United States and abroad come to see him for access to personalized care and the latest diagnostic and therapy programs.   

Dr. Wolin graduated from Reed College in Portland, Oregon, and received his MD degree From Yale School of Medicine at Yale University in New Haven, Connecticut.  After serving as intern and resident in Internal Medicine at Stanford University, he became a clinical fellow at the National Cancer Institute in Bethesda, Maryland.  He returned to Stanford to complete his Fellowship in Medical Oncology before starting his academic career at the faculty of Washington University School of Medicine in St. Louis, Missouri.

Dr. Wolin was previously the Director of Neuroendocrine and GI Oncology Program and the Director of Clinical Research at the University of Kentucky Medical Center.  For the preceding 26 years, he held key positions at Cedars–Sinai Medical Center in Los Angeles, where he founded and directed of one of the largest and most productive Carcinoid and Neuroendocrine Tumor Programs in the country.

Clinical Focus:

Dr. Wolin treats all types of carcinoid and neuroendocrine tumors, ranging from tumors of the small intestine (carcinoid), pancreas, lung and colon to those of the rectum, appendix, stomach and other sites. These include hormone-producing tumors such as carcinoid (serotonin), gastrinoma (gastrin), insulinoma (insulin), glucagonoma (glucagon), VIPoma (VIP); liver metastasis, and carcinoid syndrome. 

Dr. Wolin is a critical member of Montefiore’s outstanding multidisciplinary neuroendocrine team, that includes medical oncologists, surgeons, gastroenterologists, endocrinologists, as well as specialists in nuclear medicine, interventional radiology, diagnostic radiology, and other areas.

Research Focus:

As Director of the Neuroendocrine Tumor Program at Montefiore Einstein Center for Cancer Care, Dr. Wolin brings a robust research program to Montefiore that supports multiple clinical trials. His research efforts focus on finding the most effective and least toxic treatments, such as pasireotide, lanreotide, everolimus, other m-TOR inhibitors, targeted radiation, including peptide receptor radiotherapy with Lu-177.

Dr. Wolin has pioneered the development of neuroendocrine tumor therapy with novel somatostatin analogs, mTOR inhibitors, anti-angiogenic drugs, and peptide receptor radiotherapy (PRRT) using 177Lu-DOTATATE, as well as PET imaging with 67GA-DOTATATE scanning.

His research also pursues new directions in immunotherapy, anti-angiogenic drugs, novel targeted biologic anti-cancer treatments, as well as targeted treatment of liver metastases. In addition, Dr. Wolin directs his research towards the development of new imaging and diagnostic procedures for carcinoid/neuroendocrine tumors.

To make an appointment, please call:

Montefiore M-E Center for Cancer Center                                                                         1521 Jarrett Place                                                                                                                  Bronx, NY 10461-2601                                                                                                            (718) 862-8840

Dr. Wolin at the 2016 National NET Patient Conference:

Topic: The Role of Chemotherapy in Well-Differenciated NETs

When: Friday, September 23, 2016 at 2PM*

Be sure not to miss Dr. Wolin speak! And don’t miss him on our panel answering your questions!!

For additional info on Dr. Ed Wolin, please see his profile here.

If you would like to read some of Dr. Wolin’s pulications on PubMed, you can do so here.

SIGN UP NOW FOR THE 2016 NATIONAL NET PATIENT CONFERENCE in New Orleans, LA from September 22-24th to see Dr. Wolin and 19 other experts speak on Neuroendocrine Cancer! 

Registration is $125 per person including

  • Thursday’s Welcome Reception 
  • Breakfast, Lunch, and snacks for both Friday and Saturday
  • And keep your eyes out for some special prizes!

Registration does not include your hotel stay or travel expenses.

For more information and to buy your ticket, click here!!

*Time and Date are subject to change.